Physician
Higginbotham, Michael
Higginbotham, Michael was paid $1.60M by Medicaid between Jan 2018 and Dec 2024, across 79 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoHIGGINBOTHAM, MICHAEL
ROCKPORT, AR 72104
ROCKPORT, AR 72104
33aNPI1619992377assigned 07/13/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.60M
24GClaims73,579
24DCodes billed79
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Arkansas
Rank by total paid#11 of 437
Median peer was paid$70K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,880 | $271K | |
| 2019 | 7,357 | $209K | |
| 2020 | 5,378 | $159K | |
| 2021 | 15,225 | $305K | |
| 2022 | 17,787 | $264K | |
| 2023 | 11,352 | $226K | |
| 2024incomplete | 7,600 | $167K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 19,247 | 16,037 | $660K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 9,665 | 8,394 | $516K |
| 71046 | Radiologic examination, chest; 2 views | 4.2% | 2,545 | 2,278 | $67K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 465 | 429 | $42K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.5% | 374 | 363 | $41K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.3% | 787 | 694 | $37K |
| 87631 | 2.1% | 411 | 374 | $34K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.9% | 615 | 560 | $30K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 549 | 494 | $28K |
| 95117 | 1.5% | 1,760 | 683 | $23K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,330 | 1,233 | $14K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 256 | 228 | $13K |
67 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 215 | $12K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 214 | $10K |
| 71020 | <1% | 218 | $8K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 286 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 127 | $6K |
| 74019 | <1% | 167 | $5K | |
| 93000 | <1% | 332 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 547 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 30 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,735 | $4K |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 2,405 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 92 | $3K |
| 90734 | <1% | 313 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 154 | $3K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 26 | $2K |
| 90670 | <1% | 201 | $2K | |
| 94060 | <1% | 41 | $2K | |
| 81002 | <1% | 818 | $2K | |
| 99406 | <1% | 283 | $2K | |
| 90656 | <1% | 179 | $2K | |
| 96127 | <1% | 445 | $1K | |
| 90715 | <1% | 113 | $1K | |
| Q3014 | Telehealth originating site facility fee | <1% | 330 | $777.84 |
| 90686 | <1% | 65 | $770.70 | |
| 82962 | <1% | 653 | $561.22 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 45 | $513.02 |
| 90633 | <1% | 57 | $489.00 | |
| 81025 | <1% | 77 | $424.41 | |
| 94760 | <1% | 89 | $400.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 160 | $353.09 |
| 90710 | <1% | 29 | $280.00 | |
| 90648 | <1% | 27 | $263.40 | |
| 71045 | Radiologic examination, chest; single view | <1% | 15 | $229.50 |
| 1159F | <1% | 10,332 | $216.87 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 276 | $74.91 |
| 81003 | <1% | 28 | $55.29 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 39 | $41.61 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 36 | $24.14 |
| 3075F | <1% | 767 | $16.79 | |
| 3074F | <1% | 1,937 | $16.77 | |
| 82044 | <1% | 12 | $8.13 | |
| 3079F | <1% | 1,238 | $0.03 | |
| 3078F | <1% | 1,635 | $0.02 | |
| 1126F | 0% | 1,658 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 598 | $0.00 |
| 1125F | 0% | 2,465 | $0.00 | |
| G9716 | Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason | 0% | 167 | $0.00 |
| 1034F | 0% | 45 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 228 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 241 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 41 | $0.00 |
| 1036F | 0% | 345 | $0.00 | |
| 3044F | 0% | 59 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 50 | $0.00 |
| 1170F | 0% | 18 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 40 | $0.00 |
| 99000 | 0% | 17 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 30 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 615 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 725 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 200 | $0.00 |
| 1160F | 0% | 30 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 91 | $0.00 |
| 3288F | 0% | 30 | $0.00 | |
| 3077F | 0% | 42 | $0.00 | |
| 1158F | 0% | 18 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.